ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,445.80
0.21%
Dow Jones
39,831.60
0.69%
Gold vs US Dollar
2,387.07
1.35%
Brent Oil
82.60
0.06%
Bitcoin
65,474.26
6.38%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PhenomeX Inc (CELL)

  7. PhenomeX Inc (CELL) News

PhenomeX (CELL)

PhenomeX Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CELL
DateTimeSourceHeadlineSymbolCompany
08/02/202422:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CELLPhenomeX Inc
12/10/202314:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CELLPhenomeX Inc
03/10/202320:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
03/10/202320:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
03/10/202319:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELLPhenomeX Inc
02/10/202322:16Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:CELLPhenomeX Inc
02/10/202322:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202322:05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202322:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202322:03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202322:02Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CELLPhenomeX Inc
02/10/202313:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
29/09/202313:30Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CELLPhenomeX Inc
27/09/202313:51PR Newswire (US)PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic PlatformNASDAQ:CELLPhenomeX Inc
21/09/202313:35PR Newswire (US)PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development WorkflowsNASDAQ:CELLPhenomeX Inc
20/09/202313:48PR Newswire (US)PhenomeX to Participate in Upcoming Cell Biology ConferencesNASDAQ:CELLPhenomeX Inc
20/09/202311:05Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:CELLPhenomeX Inc
15/09/202314:08PR Newswire (US)PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free ProteomicsNASDAQ:CELLPhenomeX Inc
05/09/202321:02PR Newswire (US)PhenomeX Inc. Announces Commencement of Cash Tender Offer by BrukerNASDAQ:CELLPhenomeX Inc
31/08/202321:47Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:CELLPhenomeX Inc
28/08/202322:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CELLPhenomeX Inc
18/08/202322:21Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
17/08/202322:28Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
17/08/202322:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
17/08/202314:10Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CELLPhenomeX Inc
17/08/202314:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
17/08/202314:00Business WireBruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash TransactionNASDAQ:CELLPhenomeX Inc
14/08/202321:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELLPhenomeX Inc
14/08/202321:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELLPhenomeX Inc
14/08/202321:05PR Newswire (US)PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CELLPhenomeX Inc
 Showing the most relevant articles for your search:NASDAQ:CELL

Your Recent History

UNSW3
RAIUSDT
Rai Reflex Index
COIN
NBREUR
NASDAQ
TULY
LSE
0J4V
Heron Therapeutics
USOTC
AABVF
Aberdeen (PK)
LBNK
SSMUSDT
Speed Service Mobility
NASDAQ
NTRBW
Nutriband
NASDAQ
CBAN
Colony Bankcorp
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved